Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Apellis Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 175 | 1 | 205 | +31 |
| Shares | 65.0M | 7.30K | 64.6M | −436.2K (−0.7%) |
| Value | $2.80B | $313.0K | $4.08B | +$1.29B (+46.0%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (21)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 250,000 | $10.7M |
| Ghost Tree Capital, LLC | 225,000 | $9.65M |
| Woodline Partners LP | 171,419 | $7.36M |
| Millennium Management LLC | 158,571 | $6.80M |
| California Public Employees Retirement System | 122,358 | $5.25M |
| Burrage Capital Management LLC | 80,727 | $3.46M |
| Mackay Shields LLC | 32,400 | $1.39M |
| AlphaCrest Capital Management LLC | 18,500 | $794.0K |
| Duality Advisers, LP | 15,188 | $652.0K |
| Los Angeles Capital Management LLC | 13,611 | $584.0K |
| Eversept Partners, LP | 12,900 | $553.5K |
| Algert Global LLC | 8,979 | $385.0K |
| Engineers Gate Manager LP | 7,530 | $323.0K |
| Quantitative Systematic Strategies LLC | 6,543 | $281.0K |
| Pacer Advisors, Inc. | 1,669 | $72.0K |
| 1623 Capital LLC | 1,655 | $71.0K |
| Exane Derivatives | 1,589 | $68.2K |
| FORA Capital, LLC | 1,378 | $59.0K |
| Lazard Asset Management LLC | 1,324 | $56.0K |
| Steward Partners Investment Advisory, LLC | 750 | $32.2K |
| Sowell Financial Services LLC | 350 | $16.0K |
Not filed for Q2 2021 yet (1)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 7,300 | $313.0K |